Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "OncoTargets and therapy"
DOI: 10.2147/ott.s192631
Abstract: Aims To date, curative resection remains to be the most optimal therapeutic choice of hepatocellular carcinoma (HCC), though the overall survival (OS) remains extremely unsatisfactory. To better manage the HCC patients, we evaluated the prognosis… read more here.
Keywords: hepatocellular carcinoma; hcc; prognosis; apob ... See more keywords